5th Annual Pharmaceutical and Biotech Medical Affairs Pre-Launch Strategies Conference
September 16-17, 2020 | Boston, MA
Access Agenda
WE GUARANTEE 100% PRIVACY, YOUR INFORMATION WILL NOT BE SHARED
About the Conference:
Pre-launch medical affairs activities build a foundation for new product launches, providing a scientific and medical narrative disseminated to healthcare professionals, payers and additional stakeholders to support the health and economic benefits of new products. Whether the launch focuses on a new product iteration of an existing approved therapy, or an entirely new therapy, medical affairs executives must build comprehensive support for new products through the leverage of key opinion leaders, medical science liaisons, and commercial teams, ensuring all stakeholders both internally and externally are presented with relevant new product data in a timeline which supports the ultimate launch.
Core Topics to be Addressed:
- Creation of a scientific narrative to support launch
- Use of real-world evidence in pre-launch programs
- Pre-launch collaboration with payer stakeholders
- Leverage of KOLs & emergence of digital KOLs
- Merging pre-launch medical affairs with commercial
Program Highlights:
- Mix of presenters from companies large to small
- External stakeholder participation: Payer perspectives
- Focus on practical, real-world solutions to pre-launch
- Collaborative sessions focused on hands-on learning
Core Topics to be Addressed:
- Creation of a scientific narrative to support launch
- Use of real-world evidence in pre-launch programs
- Pre-launch collaboration with payer stakeholders
- Leverage of KOLs & emergence of digital KOLs
- Merging pre-launch medical affairs with commercial
Access Agenda
WE GUARANTEE 100% PRIVACY, YOUR INFORMATION WILL NOT BE SHARED
Audience
75 Attendees
All attendees come directly from pharmaceutical and biotech companies
Distinguished Presenters
23 Speakers
Networking
Networking time is built into the agenda to allow industry peers to connect and exchange ideas
Open Dialogue and Group Share
Each presentation is followed by 10-15 minutes of open dialogue for questions and exchange of best practices